11 HURON DR STE 200, NATICK, MA
Director Resignation - Douglas Hudson Steps Down from Allurion Board
Director Resignation - R. Jason Richey Steps Down from Board
Advances Plan to Re-List
Deloitte Dismissed as Independent Registered Public Accounting Firm
Advances Plan to Regain Listing Compliance
Intends to Appeal NYSE Notice of Delisting While Executing Plan to Regain Compliance and Expects to Remain Trading
Allurion Technologies Enters Warrant Exercise Inducement Agreement
Receives U.S. FDA Approval for the Gastric Balloon System, Featuring the Smart Capsule
Q1
FY 2025
Q3
Notice of Late Filing for Quarterly Report
Amended Quarterly Report
Amended Annual Report
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
PRER14A
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload